BioCentury
ARTICLE | Financial News

Inhibitex raises $20M

January 12, 2004 8:00 AM UTC

Infectious disease company Inhibitex raised $20 million in a series E round. Existing investors participated, and included New Enterprise Associates; William Blair Capital; Alliance Technology Ventures; Burrill Biotechnology Capital; Essex Woodlands Health Ventures; and Capital Technologies CDPQ. ...